BillionToOne, Inc. SEC filings BLLN

BillionToOne, Inc. has 178 filings in SEC EDGAR's recent list, going back to Jun 20, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

BillionToOne, Inc. SEC filings
Form Description Filed Period
CERT Filing Nov 5, 2025 —
8-A12B Filing Nov 3, 2025 —
DRSLTR Filing Sep 17, 2025 —
DRS/A Filing Sep 17, 2025 —
UPLOAD Letter from the SEC Aug 26, 2025 —
DRSLTR Filing Aug 11, 2025 —
DRS/A Filing Aug 11, 2025 —
UPLOAD Letter from the SEC Jul 17, 2025 —
DRS Filing Jun 20, 2025 —

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BLLN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2070849

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.